The Executive Director, Corporate Quality leads the creation and management of Biogen’s Global Quality Management System (QMS). The role oversees Quality Systems; internal and external cGMP audits, including audits of vendors and contract manufacturing organizations; IT Quality; Technical Product Complaints; and Central Knowledge Management, including documentation. It supports Quality and PO&T by managing risk and compliance performance, responding to regulatory changes, and identifying opportunities to improve the efficiency and effectiveness of PO&T’s cGMP systems. The role prepares semi-annual executive-level updates on the state of the QMS and informs Executive Management of potential business risks related to regulatory changes or systemic issues. It is also the principal liaison with R&D Clinical Compliance and provides guidance on ICH conformance. Oversight spans biologic products, ASOs, small molecules, gene therapy, devices, digital products, and combination products. The role is hybrid and based in RTP or Cambridge, with 25%–50% travel depending on location; more travel is required if not based in RTP. It leads integrated quality systems, policies, and standards across Biogen’s U.S. and international manufacturing sites and PO&T locations. The Executive Director oversees risk assessment, inspection response assessment, compliance metrics, regulatory monitoring, audit programs, computerized GxP systems, document and records lifecycle management, PO&T training standards, and complaint management. The role chairs the Global Management Review, establishes organizational goals and strategies, drives projects and programs within schedule and budget, manages multiple cost centers, interacts with regulatory agency representatives, and leads direct reports and managers of managers.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive